Arthritis drug does not cross placenta in pregnancy, study finds – Medical News Today


Medical News Today

Arthritis drug does not cross placenta in pregnancy, study finds
Medical News Today
The study included 16 pregnant women at ≥30 weeks gestation who were receiving certolizumab pegol at a maintenance dose (200 milligrams every 2 weeks or 400 milligrams every 4 weeks) for any of a range of approved indications, including rheumatoid …

Add a Comment

Your email address will not be published. Required fields are marked *